Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques

Journal of General Virology

Volumn 84, Issue 12, 2003, Pages 3371-3379

  Yue, Yujuan ^a   Zhou, Shan Shan ^a   Barry, Peter A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOMEGALOVIRUS VACCINE; EPITOPE; GLYCOPROTEIN B; NEUTRALIZING ANTIBODY; NUCLEIC ACID; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOPLASM; DISEASE COURSE; DISEASE MODEL; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HOST; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOTHERAPY; MEDICAL ASSESSMENT; NONHUMAN; PATHOGENESIS; PLASMID; PRIMATE; PRIORITY JOURNAL; PROTEIN DOMAIN; RHESUS MONKEY; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY; SEROCONVERSION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; MACACA MULATTA; MONKEY DISEASES; NEUTRALIZATION TESTS; SPECIES SPECIFICITY; TIME FACTORS; VIRAL ENVELOPE PROTEINS;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 8; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; MACACA; MACACA MULATTA; PRIMATES;

EID: 0347382542     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19508-0     Document Type: Article

References (58)

1. Alberola, J., Dominguez, V., Cardenoso, L. & 7 other authors (1998). Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease. J Med Virol 55, 272-280.
2. Alberola, J., Tamarit, A., Cardenoso, L., Estelles, F., Igual, R. & Navarro, D. (2001). Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytomegalovirus end-organ disease. J Med Virol 64, 35-41.
3. Alcendor, D. J., Barry, P. A., Pratt-Lowe, E. & Luciw, P. A. (1993). Analysis of the rhesus cytomegalovirus immediate-early gene promoter. Virology 194, 815-821.
4. Alford, C. A. & Britt, W. J. (1993). Cytomegalovirus. In The Human Herpesviruses, pp. 227-255. Edited by B. Roizman, R. J. Whitley & C. Lopez. New York: Raven Press.
5. Asher, D. M., Gibbs J., C. J., Lang, D. J., Gadjusek, D. C. & Chanock, R. M. (1974). Persistent shedding of cytomegalovirus in the urine of healthy rhesus monkeys. Proc Soc Exp Biol Med 145, 794-801.
6. Baroncelli, S., Barry, P. A., Capitanio, J. P., Lerche, N. W., Otsyula, M. & Mendoza, S. P. (1997). Cytomegalovirus and simian immunodeficiency virus coinfection: longitudinal study of antibody responses and disease progression. J Acquir Immune Defic Syndr 15, 5-15.
7. Baskin, G. B. (1987). Disseminated cytomegalovirus infection in immunodeficient rhesus macaques. Am J Pathol 129, 345-352.
8. Boppana, S. B. & Britt, W. J. (1995). Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 171, 1115-1121.
9. Boppana, S. B. & Britt, W. J. (1996). Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 222, 293-296.
10. Britt, W. J. & Auger, D. (1985). Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus. Virus Res 4, 31-36.
11. Britt, W. J. & Mach, M. (1996). Human cytomegalovirus glycoproteins. Intervirology 39, 401-412.
12. Britt, W. J., Vugler, L., Butfiloski, E. J. & Stephens, E. B. (1990). Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-vaccinia recombinant virus-infected cells in analysis of the human neutralizing response. J Virol 64, 1079-1085.
13. Chang, W. L. & Barry, P. A. (2003). Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J Virol 77, 5073-5083.
14. Chang, W. L., Tarantal, A. F., Zhou, S. S., Borowsky, A. D. & Barry, P. A. (2002). A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J Virol 76, 9493-9504.
15. Chee, M. S., Bankier, A. T., Beck, S. & 12 other authors (1990). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Topics Microbiol Immunol 154, 125-169.
16. Davison, A. J., Dolan, A., Akter, P., Addison, C., Dargan, D. J., Alcendor, D. J., McGeoch, D. J. & Hayward, G. S. (2003). The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 84, 17-28.
17. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H. & Calos, M. P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7, 379-387.
18. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J. & Alford, C. A. (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326, 663-667.
19. Gibson, W. (1983). Protein counterparts of human and simian cytomegaloviruses. Virol 128, 391-406.
20. Gonczol, E., Ianacone, J., Ho, W. Z., Starr, S., Meignier, B. & Plotkin, S. (1990). Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers. Vaccine 8, 130-136.
21. Hansen, S. G., Strelow, L. I., Franchi, D. C., Anders, D. G. & Wong, S. W. (2003). Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol 77, 6620-6636.
22. Hopkins, J. I., Fiander, A. N., Evans, A. S., Delchambre, M., Gheysen, D. & Borysiewicz, L. K. (1996). Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J Med Virol 49, 124-131.
23. Huff, J. L., Eberle, R., Capitanio, J., Zhou, S. S. & Barry, P. A. (2003). Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques. J Gen Virol 84, 83-92.
24. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P. & Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179, 1713-1717.
25. Kaur, A., Daniel, M. D., Hempel, D., Lee-Parritz, D., Hirsch, M. S. & Johnson, R. P. (1996). Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected macaques. J Virol 70, 7725-7733.
26. Kaur, A., Grant, R. M., Means, R. E., McClure, H., Feinberg, M. & Johnson, R. P. (1998). Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol 72, 9597-9611.
27. + T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia. J Virol 76, 3646-3658.
28. Kravitz, R. H., Sciabica, K. S., Cho, K., Luciw, P. A. & Barry, P. A. (1997). Cloning and characterization of the rhesus cytomegalovirus glycoprotein B. J Gen Virol 78, 2009-2013.
29. Kropff, B. & Mach, M. (1997). Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein. J Gen Virol 78, 1999-2007.
30. Kuhn, E. M., Stolte, N., Matz-Rensing, K., Mach, M., Stahl-Henning, C., Hunsmann, G. & Kaup, F. J. (1999). Immunohistochemical studies of productive rhesus cytomegalovirus infection in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet Pathol 36, 51-56.
31. Li, C. R., Greenberg, P. D., Gilbert, M. J., Goodrich, J. M. & Riddell, S. R. (1994). Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83, 1971-1979.
32. Liu, Y. N., Klaus, A., Kari, B., Stinski, M. F., Eckhardt, J. & Gehrz, R. C. (1991). The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans. J Virol 65, 1644-1648.
33. Lockridge, K. M., Sequar, G., Zhou, S. S., Yue, Y., Mandell, C. M. & Barry, P. A. (1999). Pathogenesis of experimental rhesus cytomegalovirus infection. J Virol 73, 9576-9583.
34. Loomis-Huff, J. E., Eberle, R., Lockridge, K. M., Rhodes, G. & Barry, P. A. (2001). Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques. Vaccine 19, 4865-4873.
35. Marshall, G. S., Rabalais, G. P., Stout, G. G. & Waldeyer, S. L. (1992). Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J Infect Dis 165, 381-384.
36. Marshall, G. S., Stout, G. G., Knights, M. E., Rabalais, G. P., Ashley, R., Miller, H. & Rossier, E. (1994). Ontogeny of glycoprotein gB-specific antibody and neutralizing activity during natural cytomegalovirus infection. J Med Virol 43, 77-83.
37. Marshall, G. S., Fenger, D. P., Stout, G. G., Knights, M. E. & Hunt, L. A. (1996). Processing of human cytomegalovirus glycoprotein B in recombinant adenovirus-infected cells. J Gen Virol 77, 1549-1557.
38. Marshall, G. S., Li, M., Stout, G. G., Louthan, M. V., Duliege, A. M., Burke, R. L. & Hunt, L. A. (2000). Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients. Viral Immunol 13, 329-341.
39. Navarro, D., Lennette, E., Tugizov, S. & Pereira, L. (1997). Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J Med Virol 52, 451-459.
40. Pitcher, C. J., Hagen, S. I., Walker, J. M., Lum, R., Mitchell, B. L., Maino, V. C., Axthelm, M. K. & Picker, L. J. (2002). Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168, 29-43.
41. Polic, B., Hengel, H., Krmpotic, A., Trgovcich, J., Pavic, I., Luccaronin, P., Jonjic, S. & Koszinowski, U. H. (1998). Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188, 1047-1054.
42. Qadri, I., Navarro, D., Paz, P. & Pereira, L. (1992). Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J Gen Virol 73, 2913-2921.
43. Rasmussen, L., Morris, S., Zipeto, D., Fessel, J., Wolitz, R., Dowling, A. & Merigan, T. C. (1995). Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis 171, 177-182.
44. Reddehase, M. J., Mutter, W., Münch, K., Bühring, H.-J. & Koszinowski, U. H. (1987). CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61, 3102-3108.
45. Reusser, P., Riddell, S. R., Meyers, J. D. & Greenberg, P. D. (1991). Cytotoxic T-lymphocyte response to cytomegalovirus after human alogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373-1380.
46. Reusser, P., Attenhofer, R., Hebart, H., Helg, C., Chapuis, B. & Einsele, H. (1997). Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 89, 3873-3879.
47. Reusser, P., Cathomas, G., Attenhofer, R., Tamm, M. & Thiel, G. (1999). Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J Infect Dis 180, 247-253.
48. Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E. & Greenberg, P. D. (1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257, 238-241.
49. Rigoutsos, I., Novotny, J., Huynh, T., Chin-Bow, S. T., Parida, L., Platt, D., Coleman, D. & Shenk, T. (2003). In silico pattern-based analysis of the human cytomegalovirus genome. J Virol 77, 4326-4344.
50. Schoppel, K., Kropff, B., Schmidt, C., Vornhagen, R. & Mach, M. (1997). The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J Infect Dis 175, 533-544.
51. Schoppel, K., Schmidt, C., Einsele, H., Hebart, H. & Mach, M. (1998). Kinetics of the antibody response against human cytomegalovirus- specific proteins in allogeneic bone marrow transplant recipients. J Infect Dis 178, 1233-1243.
52. Sequar, G., Britt, W. J., Lakeman, F. D., Lockridge, K. M., Tarara, R. P., Canfield, D. R., Zhou, S. S., Gardner, M. B. & Barry, P. A. (2002). Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis. J Virol 76, 7661-7671.
53. Spaete, R. R., Thayer, R. M., Probert, W. S., Masiarz, F. R., Chamberlain, S. H., Rasmussen, L., Merigan, T. C. & Pachl, C. (1988). Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167, 207-225.
54. Swack, N. S. & Hsiung, G. D. (1982). Natural and experimental simian cytomegalovirus infections at a primate center. J Med Primatol 11, 169-177.
55. Urban, M., Klein, M., Britt, W. J., Hassfurther, E. & Mach, M. (1996). Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response. J Gen Virol 77, 1537-1547.
56. Utz, U., Britt, W., Vugler, L. & Mach, M. (1989). Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol 63, 1995-2001.
57. Vogel, P., Weigler, B. J., Kerr, H., Hendrickx, A. & Barry, P. A. (1994). Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab Anim Sci 44, 25-30.
58. Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D. & Riddell, S. R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333, 1038-1044.